Aspiriant, LLC Medtronic PLC Transaction History

Aspiriant, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$82.84 - $88.09 $31,479 - $33,474	-380 Reduced 12.79%	2,592 $225,000
Q4 2023 Jan 26, 2024	SELL	$69.43 - $83.43 $38,811 - $46,637	-559 Reduced 15.83%	2,972 $244,000
Q3 2023 Oct 17, 2023	BUY	$78.22 - $90.4 $61,480 - $71,054	786 Added 28.63%	3,531 $276,000
Q2 2023 Jul 19, 2023	BUY	$79.47 - $91.38 $10,966 - $12,610	138 Added 5.29%	2,745 $241,000
Q1 2023 Apr 27, 2023	BUY	$76.72 - $87.58 $200,009 - $228,321	2,607 New	2,607 $210,000
Q3 2022 Oct 28, 2022	SELL	$80.75 - $95.31 $15,181 - $17,918	-188 Reduced 5.85%	3,028 $245,000
Q2 2022 Jul 25, 2022	BUY	$87.4 - $113.09 $99,286 - $128,470	1,136 Added 54.62%	3,216 $289,000
Q1 2022 May 06, 2022	BUY	$100.58 - $112.38 $209,206 - $233,750	2,080 New	2,080 $231,000
Q4 2018 Feb 04, 2019	SELL	$85.8 - $99.49 $174,088 - $201,865	-2,029 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$85.91 - $99.17 $174,311 - $201,215	2,029 New	2,029 $200,000
Q2 2018 Aug 07, 2018	SELL	$77.48 - $87.83 $265,678 - $301,169	-3,429 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$76.55 - $87.26 $262,489 - $299,214	3,429 New	3,429 $275,000

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspiriant, LLC with notifications on news.